Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
AssigneeAkagera Medicines, Inc.
InventorsDaryl C. Drummond, Dmitri B. Kirpotin, Mark E. Hayes, Alexander Koshkaryev, Ross B. Fulton
Life of this patent
Estimating the term…
Loading patent…
AssigneeAkagera Medicines, Inc.
InventorsDaryl C. Drummond, Dmitri B. Kirpotin, Mark E. Hayes, Alexander Koshkaryev, Ross B. Fulton
Estimating the term…
The present disclosure provides for improved compositions of ionizable lipid nanoparticles for the delivery of therapeutic nucleic acids to cells. Anionic phospholipids, including phosphatidylserine and phosphatidylglycerol are included in the lipid nanoparticles to increase the transfection efficiency in human dendritic cells. The further incorporation of mono-unsaturated alkyl chain analogs in dimethylaminopropyl-dioxolane or heterocyclic ketal ionizable lipids in the formulation demonstrated high levels of transfection in human dendritic cells, compared to other ionizable lipids in the same family, and demonstrated good stability to oxidative damage. Finally, the use of an ammonium salt of phosphatidylserine allows for the efficient production of PS-targeted LNPs.
A nucleic acid lipid nanoparticle (LNP) composition targeting a mRNA nucleic acid encapsulated in lipidic nanoparticles to human dendritic cells, the lipidic nanoparticles consisting of:
Dependencies are inferred from the claim text.